Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-09-07

FDA Approved: EPTIFIBATIDE — Original Application (Hainan Shuangcheng Pharmaceuticals Co., Ltd.)

View source ↗

Summary

The FDA approved the original ANDA for Eptifibatide from Hainan Shuangcheng Pharmaceuticals Co., Ltd., authorizing a generic version of the antiplatelet drug fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • EPTIFIBATIDE (EPTIFIBATIDE)

Snippet

ORIG AP for EPTIFIBATIDE (EPTIFIBATIDE)